Literature DB >> 19200322

Acetylation of fluoroquinolone antimicrobial agents by an Escherichia coli strain isolated from a municipal wastewater treatment plant.

C M Jung1, T M Heinze, R Strakosha, C A Elkins, J B Sutherland.   

Abstract

AIMS: To isolate environmental bacteria capable of transforming fluoroquinolones to inactive molecules. METHODS AND
RESULTS: Bacteria were isolated from the aerobic liquor of a wastewater treatment plant on a medium containing norfloxacin (100 mg l(-1)). Twenty-two isolates were highly resistant (minimal inhibitory concentration: 6.25-200 microg ml(-1)) to five fluoroquinolones and six of them were positive by PCR amplification for the aminoglycoside resistance gene aac(6')-Ib. Of these, only Escherichia coli strain LR09 had the ciprofloxacin-acetylating variant gene aac(6')-Ib-cr; HPLC and mass spectrometry showed that this strain transformed both ciprofloxacin and norfloxacin by N-acetylation. This bacterium also had mutations in the quinolone-resistance determining regions of the gyrA and parC genes.
CONCLUSIONS: An E. coli isolate from wastewater, which possessed at least two distinct fluoroquinolone resistance mechanisms, inactivated ciprofloxacin and norfloxacin by N-acetylation. SIGNIFICANCE AND IMPACT OF THE STUDY: This is the first report of N-acetylation of fluoroquinolones by an aac(6')-Ib-cr-containing bacterium from an environmental source.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19200322     DOI: 10.1111/j.1365-2672.2008.04026.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  15 in total

1.  Environmental metabolites of fluoroquinolones: synthesis, fractionation and toxicological assessment of some biologically active metabolites of ciprofloxacin.

Authors:  Gareth Lewis; Albert Juhasz; Euan Smith
Journal:  Environ Sci Pollut Res Int       Date:  2012-02-04       Impact factor: 4.223

2.  Practical disk-based method for detection of Escherichia coli clinical isolates producing the fluoroquinolone-modifying enzyme AAC(6')-Ib-cr.

Authors:  Jun-Ichi Wachino; Kunikazu Yamane; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2011-04-06       Impact factor: 5.948

3.  Modification of norfloxacin by a Microbacterium sp. strain isolated from a wastewater treatment plant.

Authors:  Dae-Wi Kim; Thomas M Heinze; Bong-Soo Kim; Laura K Schnackenberg; Kellie A Woodling; John B Sutherland
Journal:  Appl Environ Microbiol       Date:  2011-07-01       Impact factor: 4.792

4.  Biodegradation potential of ofloxacin and its resulting transformation products during photolytic and photocatalytic treatment.

Authors:  M I Vasquez; E Hapeshi; D Fatta-Kassinos; K Kümmerer
Journal:  Environ Sci Pollut Res Int       Date:  2012-08-02       Impact factor: 4.223

5.  Ciprofloxacin treatment failure in a murine model of pyelonephritis due to an AAC(6')-Ib-cr-producing Escherichia coli strain susceptible to ciprofloxacin in vitro.

Authors:  T Guillard; E Cambau; F Chau; L Massias; C de Champs; B Fantin
Journal:  Antimicrob Agents Chemother       Date:  2013-09-09       Impact factor: 5.191

6.  Plasmid-Mediated Ciprofloxacin Resistance Imparts a Selective Advantage on Escherichia coli ST131.

Authors:  Minh-Duy Phan; Kate M Peters; Laura Alvarez Fraga; Steven C Wallis; Steven J Hancock; Nguyen Thi Khanh Nhu; Brian M Forde; Michelle J Bauer; David L Paterson; Scott A Beatson; Jeffrey Lipman; Mark A Schembri
Journal:  Antimicrob Agents Chemother       Date:  2021-11-15       Impact factor: 5.938

Review 7.  Microbial transformations of antimicrobial quinolones and related drugs.

Authors:  Igor A Parshikov; John B Sutherland
Journal:  J Ind Microbiol Biotechnol       Date:  2012-09-25       Impact factor: 3.346

Review 8.  Plasmid-mediated quinolone resistance: a multifaceted threat.

Authors:  Jacob Strahilevitz; George A Jacoby; David C Hooper; Ari Robicsek
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

9.  Identification of the enzyme responsible for N-acetylation of norfloxacin by Microbacterium sp. Strain 4N2-2.

Authors:  Dae-Wi Kim; Jinhui Feng; Huizhong Chen; Ohgew Kweon; Yuan Gao; Li-Rong Yu; Vanessa J Burrowes; John B Sutherland
Journal:  Appl Environ Microbiol       Date:  2012-10-26       Impact factor: 4.792

10.  Metabolite proving fungal cleavage of the aromatic core part of a fluoroquinolone antibiotic.

Authors:  Heinz-Georg Wetzstein; Josef Schneider; Wolfgang Karl
Journal:  AMB Express       Date:  2012-01-03       Impact factor: 3.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.